Related Experiment Video
Updated: Aug 22, 2026

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery
S Shariatmadar1, J R Storry, L Sausais
1University of Miami Jackson Memorial Hospital, Holtz Center, Room 2023, 1611 NW 12th Avenue, Miami, Florida, 33136, USA.
Second- and third-generation cephalosporins, notably cefotetan, are increasingly implicated in severe, sometimes fatal immunemediated hemolytic anemia. We describe a 26-year-old woman who developed severe hemolytic anemia 2 weeks after receiving a single prophylactic dose of cefotetan during cesarean delivery. The patient's DAT was weakly reactive for IgG and her serum reacted with cefotetan-coated RBCs. The antibody had a titer of 4,096 by antiglobulin testing. The patient required treatment with two units of PRBCs and experienced gradual resolution of hemolysis. Our case emphasizes the need for increased awareness of delayed onset hemolytic anemia following prophylactic use of cefotetan.
Second- and third-generation cephalosporins, notably cefotetan, are increasingly implicated in severe, sometimes fatal immunemediated hemolytic anemia. We describe a 26-year-old woman who developed severe hemolytic anemia 2 weeks after receiving a single prophylactic dose of cefotetan during cesarean delivery. The patient's DAT was weakly reactive for IgG and her serum reacted with cefotetan-coated RBCs. The antibody had a titer of 4,096 by antiglobulin testing. The patient required treatment with two units of PRBCs and experienced gradual resolution of hemolysis. Our case emphasizes the need for increased awareness of delayed onset hemolytic anemia following prophylactic use of cefotetan.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Cryptococcal Meningitis
Rocky Mountain Spotted Fever